Blister
Sotalol Hydrochloride Tablet
Product Images NDC 68084-654
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 68084-654). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton
This is a description for Sotalol Hydrochloride Tablets prescribed to patients. It comes in a pack of 100 tablets (10 x 10) and each tablet contains B0mg ysrochioride. The package should be kept between 20" 1025°C (88" to 7°F) with excursions permitted between T315.30°C (58”1) see USP Contoled Room Temperature]. The medication is distributed by American Health Packing, Columbus, Ghio 45217. The product contained in the package is from B3 60505-0680, Apotex Corp. Please keep this drug out of the reach of children, and do not use it if the blister of packaging has any damage. Recommended dosage should be seen in the package insert for full prescribing information.*
Figure 1
Figure 2
This appears to be a graph showing the recurrence-free survival rate of patients taking oral Sotalol versus those taking a placebo. The survival rate is measured in days and is represented by the time axis. The data is divided into four groups: 80 mg, 120 mg, 160 mg, and placebo. The log-rank p-value is also provided for each group.*
C7080b83 4edf Eeb3 E053 2995a90acf0d
Figure1.jpg (Image 01)
Image 02
This appears to be a graph displaying the "Recurrence-Free Survival" rates for a drug called "Sotalol Hydrochloride AF" compared to a placebo. The y-axis shows survival rates ranging from 0.0 to 1.0, while the x-axis shows the time in days (up to 180 days). The drug appears to have a higher survival rate compared to the placebo.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
